Amundi Edwards Lifesciences Corp Transaction History

Amundi

$276 Billion
Q2 2025

A detailed history of Amundi transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Amundi holds 3,461,129 shares of EW stock, worth $267 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,461,129

Previous 2,919,186 18.56%

Holding current value

$267 Million

Previous $212 Million 27.94%

% of portfolio

0.1%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$67.07 - $78.22 $36.3 Million - $42.4 Million	541,943 Added 18.56%	3,461,129 $271 Million
Q1 2025 May 15, 2025	SELL	$67.95 - $76.19 $27.3 Million - $30.6 Million	-402,011 Reduced 12.1%	2,919,186 $212 Million
Q4 2024 Feb 07, 2025	SELL	$64.54 - $75.92 $10.4 Million - $12.2 Million	-161,211 Reduced 4.63%	3,321,197 $246 Million
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $104 Million - $163 Million	-1,735,109 Reduced 33.26%	3,482,408 $230 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $25.5 Million - $28.5 Million	-302,340 Reduced 5.48%	5,217,517 $482 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $51.6 Million - $67.9 Million	-710,696 Reduced 11.41%	5,519,857 $527 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $19.7 Million - $24.8 Million	318,902 Added 5.39%	6,230,553 $475 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $104 Million - $140 Million	-1,498,503 Reduced 20.22%	5,911,651 $410 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $74.5 Million - $86.3 Million	914,993 Added 14.09%	7,410,154 $699 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $120 Million - $136 Million	-1,613,687 Reduced 19.9%	6,495,161 $537 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $114 Million - $146 Million	1,673,580 Added 26.01%	8,108,848 $605 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $95.1 Million - $124 Million	1,154,632 Added 21.87%	6,435,268 $561 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $4.14 Million - $6.15 Million	-47,911 Reduced 0.9%	5,280,636 $511 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $89.8 Million - $113 Million	881,088 Added 19.81%	5,328,547 $658 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $37.4 Million - $46 Million	-351,962 Reduced 7.33%	4,447,459 $538 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $3.05 Million - $3.63 Million	29,607 Added 0.62%	4,799,421 $543 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $400 Million - $500 Million	4,769,814 New	4,769,814 $494 Million

Others Institutions Holding EW

# of Institutions

1,448

Shares Held

485M

Call Options Held

2.76M

Put Options Held

1.54M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $47.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account